Accessibility Menu
 
AlzChem Group Ag logo

AlzChem Group Ag

(ETR) ACT

Current Price$161.80
Market Cap$1.64B
Since IPO (2017)+704%
5 Year+535%
1 Year+63%
1 Month+0%

AlzChem Group Ag Financials at a Glance

Market Cap

$1.64B

Revenue (TTM)

$562.12M

Net Income (TTM)

$63.46M

EPS (TTM)

$6.28

P/E Ratio

25.77

Dividend

$1.80

Beta (Volatility)

-0.06 (Low)

Price

$161.80

Volume

18,752

Open

$166.00

Previous Close

$161.80

Daily Range

$160.00 - $166.00

52-Week Range

$73.70 - $179.40

ACT News

No articles available.

ACT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AlzChem Group Ag

Industry

Chemicals

Sector

Materials

Employees

1,765

CEO

Andreas Niedermaier

Headquarters

Trostberg, 83308, DE

ACT Financials

Key Financial Metrics (TTM)

Gross Margin

32%

Operating Margin

15%

Net Income Margin

11%

Return on Equity

27%

Return on Capital

17%

Return on Assets

10%

Earnings Yield

3.88%

Dividend Yield

0.01%

Payout Ratio

28.66%

Stock Overview

Market Cap

$1.64B

Shares Outstanding

10.12M

Volume

18.75K

Short Interest

0.00%

Avg. Volume

23.78K

Financials (TTM)

Gross Profit

$177.59M

Operating Income

$82.79M

EBITDA

$109.44M

Operating Cash Flow

$137.01M

Capital Expenditure

$97.79M

Free Cash Flow

$39.22M

Cash & ST Invst.

$78.20M

Total Debt

$45.47M

AlzChem Group Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$137.29M

+0.0%

Gross Profit

$59.75M

-182.8%

Gross Margin

-43.52%

N/A

Market Cap

$1.64B

N/A

Market Cap/Employee

$1.06M

N/A

Employees

1,541

N/A

Net Income

$16.74M

+10.7%

EBITDA

$21.10M

-2.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$32.73M

+217.0%

Accounts Receivable

$94.64M

+12.0%

Inventory

$116.00M

+14.7%

Long Term Debt

$37.23M

-14.2%

Short Term Debt

$8.24M

-12.5%

Return on Assets

10.27%

N/A

Return on Invested Capital

16.60%

N/A

Free Cash Flow

$5.67M

-122.8%

Operating Cash Flow

$21.72M

-28.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LXS.DELanxess AG
$17.66+3.76%
SZG.DESalzgitter AG
$35.14-3.88%
RKVA.FWesdome Gold Mines Ltd.
$14.19+2.31%
VBK.DEVERBIO Vereinigte BioEnergie AG
$43.56-1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ACT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.